mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |